Omicron remains not blocked by most antibody treatments, showing the initial test
Antibodic treatment in the previous variant of Coronavirus, including Delta, can reduce the risk of Covid-19 to 85 percent.
In the midst of a covid-19 explosion surge in cases throughout the Majorly world caused by a very contagious omicron variant, the study shows that effective antibody treatments for previous coronavirus strains may be ineffective against new variants.
According to a report by the journal Nature, some pre-print publications say that Omicron is "total or partly resistant to all treatments available today based on monoclonal antibodies". As a result, many antibody therapy producers have conceded their products because of the lower potential for Omicron, compared to other variants.
Only two antibodies showed strong evidence, the report stated, the Sotrovimab, was developed...
